1 / 9

Systemic Lupus Erythematosus Treatment Market Opportunity Analysis 2018-2026

Systemic Lupus Erythematosus (SLE) is chronic autoimmune disorder. It is characterized by excess production of the antibodies that attacks body’s own cells and vital organs. Various symptoms associated with the disease includes joint pain, swelling, rashes over face (butterfly rash) and other body area, severe fatigue, hair loss, anemia, and Raynaud’s phenomenon etc. SLE can also affect vital body organs such as heart, kidney, lungs, and behavioral changes. Exact causes of the disease is unknown, however, hereditary and environmental factors could be lead to SLE.

RupeshD
Download Presentation

Systemic Lupus Erythematosus Treatment Market Opportunity Analysis 2018-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Systemic Lupus Erythematosus Treatment Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018- 2026 © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Systemic Lupus Erythematosus Treatment Market – Overview Systemic Lupus Erythematosus (SLE) is chronic autoimmune disorder. It is characterized by excess production of the antibodies that attacks body’s own cells and vital organs. Various symptoms associated with the disease includes joint pain, swelling, rashes over face (butterfly rash) and other body area, severe fatigue, hair loss, anemia, and Raynaud’s phenomenon etc. SLE can also affect vital body organs such as heart, kidney, lungs, and behavioral changes. Exact causes of the disease is unknown, however, hereditary and environmental factors could be lead to SLE. There is no direct cure available for SLE, however, symptomatic treatment can be administered to lower or eliminate symptoms associated with disease. Major classes of drugs commonly used are antimalarial agents such as chlorquine and hydrochlorquine; topical steroid cream for rashes; NSAIDS for joint pain; and fever steroidal medication such as glucocorticoids through IV or oral route and immunosuppressive agents to lower immune response from the antibodies. Rise in incidence of SLE is one of major factors driving growth of the systemic lupus erythematosus treatment market. According to study published in the Expert Review of Clinical Immunology in 2017, the global incidence rate varied from about 0.3–23.7 per 100,000 person and the prevalence rates varied in the range from 6.5 to 178.0 per 100,000 people. Key companies are entering into collaborations for research and development in systemic lupus erythematosus, which is expected to support growth of the market. Click To Continue Reading on Systemic Lupus Erythematosus Treatment Market © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Systemic Lupus Erythematosus Treatment MarketTaxonomy: By Treatment Type Antimalarial Drugs Chlorquine Hydrochlorquine Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) Cytotoxic and Immunosuppressive Drugs Cyclosporine Cyclophosphamide Methotrexate Mycophenolate Mofetil Tacrolimus Biologics B-Cell modulators T-Cell modulators Pro-inflammatory and cytokine inhibitors Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1540 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Systemic Lupus Erythematosus Treatment MarketTaxonomy: By Route of Administration Intravenous Sub-cutaneous Oral Topical By Distribution Channel Retail Pharmacy Online Pharmacy Antimalarial is often used in mild SLE conditions, whereas, glucocorticoids and NSAIDS are commonly used in mild to moderate conditions. These are also preferred treatment in case of complications associated with SLE, where organs are damaging due to the disease. NSAIDS and immunosuppressive drugs segments hold a larger share in the market than other classes due to their proven efficacy in reducing symptoms and wider use in SLE conditions with organ complication. Biologics drugs segment are slowly gaining traction in the market with better outcomes and more patient compliance. Guidelines for use of biologic are also boosting confidence among physicians for adoption of biologics, as treatment for systemic lupus erythematosus. © Coherent market Insights. All Rights Reserved

  5. REPORT DESCRIPTION Systemic Lupus Erythematosus Treatment Market: Key Players Major players involved in the global systemic lupus erythematosus treatment market include: GlaxoSmithKline Plc (GSK) ● F. Hoffmann-La Roche Ltd ● Anthera Pharmaceuticals Inc. ● Bristol-Myers Squibb ● Eli Lilly ● Pfizer Limited ● Merck KgaA ● Immupharma Plc, ● © Coherent market Insights. All Rights Reserved

  6. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  7. ABOUT COHERENT MARKET INSIGHTS Industries we cater SECTOR COVERAGE Healthcare CLINICAL DIAGNOSTIC HEALTHCARE IT BIOTECHNOLOGY PHARMACEUTICAL MEDICAL IMAGING MEDICAL DEVICES Chemicals & Materials Speciality and Fine Chemicals Bulk Chemicals Advanced Materials Green Chemicals Polymers & Resins Food Ingredients Cosmetic Ingredients © Coherent market Insights. All Rights Reserved

  8. ABOUT COHERENT MARKET INSIGHTS KEY STATS RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES 100+ Insights Published Per Year CUSTOMIZED SOLUTIONS COUNTRY ANALYSIS Consulting Projects Till Date 150+ CONSULT PROJECTS SURVEY RESEAR CH EXCEL FORECAST DATABASE 125+ COMPETITIVE ASSESSMENT Clients Worldwide Per Year 110+ TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  9. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related